Rhenman & Partners Asset Management Ab Iovance Biotherapeutics, Inc. Transaction History

Rhenman & Partners Asset Management Ab

  • $840 Million
  • Q1 2025

A detailed history of Rhenman & Partners Asset Management Ab transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 647,827 shares of IOVA stock, worth $1.17 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
647,827
Previous 1,235,448 47.56%
Holding current value
$1.17 Million
Previous $9.14 Million 76.41%
% of portfolio
0.26%
Previous 0.95%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$3.33 - $7.79 $1.96 Million - $4.58 Million
-587,621 Reduced 47.56%
647,827 $2.16 Million
Q4 2024

Feb 13, 2025
BUY
$7.17 - $12.28 $1.31 Million - $2.25 Million
182,948 Added 17.38%
1,235,448 $9.14 Million
Q3 2024

Nov 13, 2024
BUY
$7.28 - $11.9 $964,600 - $1.58 Million
132,500 Added 14.4%
1,052,500 $9.88 Million
Q2 2024

Aug 13, 2024
SELL
$7.78 - $14.19 $272,300 - $496,650
-35,000 Reduced 3.66%
920,000 $7.38 Million
Q1 2024

May 14, 2024
SELL
$7.59 - $17.47 $1.23 Million - $2.83 Million
-161,818 Reduced 14.49%
955,000 $14.2 Million
Q4 2023

Feb 13, 2024
BUY
$3.3 - $8.89 $550,499 - $1.48 Million
166,818 Added 17.56%
1,116,818 $9.08 Million
Q3 2023

Nov 13, 2023
BUY
$4.44 - $8.79 $4.06 Million - $8.04 Million
915,000 Added 2614.29%
950,000 $4.32 Million
Q3 2023

Nov 09, 2023
SELL
$4.44 - $8.79 $3.62 Million - $7.16 Million
-815,000 Reduced 95.88%
35,000 $159,000
Q2 2023

Aug 11, 2023
BUY
$5.36 - $9.06 $878,128 - $1.48 Million
163,830 Added 23.88%
850,000 $5.98 Million
Q1 2023

May 11, 2023
SELL
$5.53 - $8.22 $985,490 - $1.46 Million
-178,208 Reduced 20.62%
686,170 $4.19 Million
Q4 2022

Feb 13, 2023
BUY
$5.62 - $10.0 $1.99 Million - $3.54 Million
354,378 Added 69.49%
864,378 $5.52 Million
Q3 2022

Nov 14, 2022
SELL
$9.53 - $13.11 $190,600 - $262,200
-20,000 Reduced 3.77%
510,000 $4.76 Million
Q2 2022

Aug 12, 2022
BUY
$6.38 - $18.33 $350,900 - $1.01 Million
55,000 Added 11.58%
530,000 $5.85 Million
Q1 2022

May 13, 2022
SELL
$12.38 - $19.1 $1.55 Million - $2.39 Million
-125,000 Reduced 20.83%
475,000 $7.91 Million
Q4 2021

Feb 11, 2022
BUY
$16.55 - $27.63 $4.63 Million - $7.74 Million
280,000 Added 87.5%
600,000 $11.7 Million
Q3 2021

Nov 12, 2021
BUY
$20.35 - $26.63 $407,000 - $532,600
20,000 Added 6.67%
320,000 $7.89 Million
Q2 2021

Aug 13, 2021
BUY
$16.33 - $33.07 $81,649 - $165,350
5,000 Added 1.69%
300,000 $7.81 Million
Q1 2021

May 14, 2021
SELL
$28.67 - $52.59 $716,750 - $1.31 Million
-25,000 Reduced 7.81%
295,000 $9.34 Million
Q4 2020

Jan 19, 2021
SELL
$28.04 - $50.26 $560,800 - $1.01 Million
-20,000 Reduced 5.88%
320,000 $14.8 Million
Q2 2020

Jul 16, 2020
SELL
$27.21 - $41.0 $680,250 - $1.03 Million
-25,000 Reduced 6.85%
340,000 $9.33 Million
Q1 2020

Apr 16, 2020
SELL
$19.54 - $38.85 $2.15 Million - $4.27 Million
-110,000 Reduced 23.16%
365,000 $10.9 Million
Q4 2019

Jan 17, 2020
SELL
$17.95 - $29.41 $807,750 - $1.32 Million
-45,000 Reduced 8.65%
475,000 $13.1 Million
Q3 2019

Oct 16, 2019
SELL
$17.99 - $26.0 $4.15 Million - $6 Million
-230,700 Reduced 30.73%
520,000 $9.46 Million
Q2 2019

Jul 22, 2019
SELL
$9.78 - $24.52 $1.26 Million - $3.16 Million
-128,900 Reduced 14.65%
750,700 $18.4 Million
Q1 2019

Apr 11, 2019
SELL
$8.41 - $11.26 $2.74 Million - $3.67 Million
-325,895 Reduced 27.03%
879,600 $8.37 Million
Q4 2018

Feb 05, 2019
SELL
$7.51 - $11.93 $638,350 - $1.01 Million
-85,000 Reduced 6.59%
1,205,495 $10.7 Million
Q3 2018

Oct 03, 2018
BUY
$11.25 - $17.7 $4.98 Million - $7.84 Million
443,019 Added 52.28%
1,290,495 $14.5 Million
Q2 2018

Jul 20, 2018
SELL
$12.45 - $16.95 $1.2 Million - $1.64 Million
-96,709 Reduced 10.24%
847,476 $10.8 Million
Q4 2017

Jan 19, 2018
BUY
$6.65 - $9.25 $1.55 Million - $2.16 Million
233,022 Added 32.77%
944,185 $7.55 Million
Q3 2017

Oct 13, 2017
BUY
$4.45 - $8.55 $3.16 Million - $6.08 Million
711,163
711,163 $5.51 Million

Others Institutions Holding IOVA

# of Institutions
334
Shares Held
247M
Call Options Held
1.34M
Put Options Held
1.61M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $284M
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email